A conceptual review on systems biology in health and diseases: from biological networks to modern therapeutics

Human physiology is an ensemble of various biological processes spanning from intracellular molecular interactions to the whole body phenotypic response. Systems biology endures to decipher these multi-scale biological networks and bridge the link between genotype to phenotype. The structure and dynamic properties of these networks are responsible for controlling and deciding the phenotypic state of a cell. Several cells and various tissues coordinate together to generate an organ level response which further regulates the ultimate physiological state. The overall network embeds a hierarchical regulatory structure, which when unusually perturbed can lead to undesirable physiological state termed as disease. Here, we treat a disease diagnosis problem analogous to a fault diagnosis problem in engineering systems. Accordingly we review the application of engineering methodologies to address human diseases from systems biological perspective. The review highlights potential networks and modeling approaches used for analyzing human diseases. The application of such analysis is illustrated in the case of cancer and diabetes. We put forth a concept of cell-to-human framework comprising of five modules (data mining, networking, modeling, experimental and validation) for addressing human physiology and diseases based on a paradigm of system level analysis. The review overtly emphasizes on the importance of multi-scale biological networks and subsequent modeling and analysis for drug target identification and designing efficient therapies.

[1]  O. Ebenhöh,et al.  Systems approaches to modelling pathways and networks. , 2011, Briefings in functional genomics.

[2]  Rune Linding,et al.  Directional and quantitative phosphorylation networks. , 2008, Briefings in functional genomics & proteomics.

[3]  Susumu Goto,et al.  KEGG: Kyoto Encyclopedia of Genes and Genomes , 2000, Nucleic Acids Res..

[4]  L. Hood,et al.  Reverse Engineering of Biological Complexity , 2007 .

[5]  G. Hays,et al.  Identification of genetically and oceanographically distinct blooms of jellyfish , 2013, Journal of The Royal Society Interface.

[6]  Rachael Hageman Blair,et al.  Mathematical and Statistical Modeling in Cancer Systems Biology , 2012, Front. Physio..

[7]  Avi Ma’ayan Introduction to Network Analysis in Systems Biology , 2011, Science Signaling.

[8]  Robert S Parker,et al.  Dynamic modeling of free fatty acid, glucose, and insulin: an extended "minimal model". , 2006, Diabetes technology & therapeutics.

[9]  C. Rao,et al.  Control motifs for intracellular regulatory networks. , 2001, Annual review of biomedical engineering.

[10]  D. Galas,et al.  Diseases as network perturbations. , 2010, Current opinion in biotechnology.

[11]  Devjit Tripathy,et al.  Defects in Insulin Secretion and Action in the Pathogenesis of Type 2 Diabetes Mellitus , 2010, Current diabetes reports.

[12]  Jacky L. Snoep,et al.  BioModels Database: a free, centralized database of curated, published, quantitative kinetic models of biochemical and cellular systems , 2005, Nucleic Acids Res..

[13]  Bernhard O Palsson,et al.  Microbial regulatory and metabolic networks. , 2007, Current opinion in biotechnology.

[14]  E. Chautard,et al.  Interaction networks: from protein functions to drug discovery. A review. , 2009, Pathologie-biologie.

[15]  A. De Gaetano,et al.  Mathematical models of diabetes progression. , 2008, American journal of physiology. Endocrinology and metabolism.

[16]  H. A. van den Berg,et al.  Mathematical models of energy homeostasis , 2008, Journal of The Royal Society Interface.

[17]  A. Barabasi,et al.  Network medicine--from obesity to the "diseasome". , 2007, The New England journal of medicine.

[18]  U. Alon Biological Networks: The Tinkerer as an Engineer , 2003, Science.

[19]  D. Geman,et al.  Computational Medicine: Translating Models to Clinical Care , 2012 .

[20]  Tohru Mizushima [Identification of a molecular mechanism for actions of existing medicines and its application for drug development]. , 2012, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.

[21]  Matthew A. Hibbs,et al.  Visualization of omics data for systems biology , 2010, Nature Methods.

[22]  David J. Klinke,et al.  Integrating Epidemiological Data into a Mechanistic Model of Type 2 Diabetes: Validating the Prevalence of Virtual Patients , 2008, Annals of Biomedical Engineering.

[23]  Mehmet Koyut Algorithmic and analytical methods in network biology , 2009 .

[24]  Barbara M. Bakker,et al.  Emergence of the silicon human and network targeting drugs. , 2012, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[25]  O. Reséndis-Antonio,et al.  Modeling Core Metabolism in Cancer Cells: Surveying the Topology Underlying the Warburg Effect , 2010, PloS one.

[26]  Rakesh K Jain,et al.  Can we identify predictive biomarkers for antiangiogenic therapy of cancer using mathematical modeling? , 2013, Journal of the National Cancer Institute.

[27]  P. Aloy,et al.  Unveiling the role of network and systems biology in drug discovery. , 2010, Trends in pharmacological sciences.

[28]  Eduardo Sontag,et al.  Untangling the wires: A strategy to trace functional interactions in signaling and gene networks , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[29]  Meindert Danhof,et al.  Disease System Analysis: Basic Disease Progression Models in Degenerative Disease , 2005, Pharmaceutical Research.

[30]  Ronan M. T. Fleming,et al.  Quantitative prediction of cellular metabolism with constraint-based models: the COBRA Toolbox v2.0 , 2007, Nature Protocols.

[31]  J. Ferrell Self-perpetuating states in signal transduction: positive feedback, double-negative feedback and bistability. , 2002, Current opinion in cell biology.

[32]  Paolo Vicini Kinetic models at the intersection of biology, engineering and medicine , 2008 .

[33]  Ronan M. T. Fleming,et al.  Quantitative prediction of cellular metabolism with constraint-based models: the COBRA Toolbox v2.0 , 2007, Nature Protocols.

[34]  S. Shen-Orr,et al.  Network motifs: simple building blocks of complex networks. , 2002, Science.

[35]  Xingming Zhao,et al.  Computational Systems Biology , 2013, TheScientificWorldJournal.

[36]  Hyun Uk Kim,et al.  Data integration and analysis of biological networks. , 2010, Current opinion in biotechnology.

[37]  Rui Jiang,et al.  Constructing human phenome-interactome networks for the prioritization of candidate genes , 2012 .

[38]  M. Vidal,et al.  Integrating 'omic' information: a bridge between genomics and systems biology. , 2003, Trends in genetics : TIG.

[39]  M. DePamphilis,et al.  HUMAN DISEASE , 1957, The Ulster Medical Journal.

[40]  E. Wang,et al.  Dynamic modeling and analysis of cancer cellular network motifs. , 2011, Integrative biology : quantitative biosciences from nano to macro.

[41]  J. Nielsen,et al.  Translational and systems medicine , 2012, Journal of internal medicine.

[42]  Ben van Ommen,et al.  Nutritional Systems Biology Modeling: From Molecular Mechanisms to Physiology , 2009, PLoS Comput. Biol..

[43]  Wolfgang Weiss,et al.  A Computational Systems Biology Software Platform for Multiscale Modeling and Simulation: Integrating Whole-Body Physiology, Disease Biology, and Molecular Reaction Networks , 2011, Front. Physio..

[44]  P. Bork,et al.  Association of genes to genetically inherited diseases using data mining , 2002, Nature Genetics.

[45]  K. Shaitan,et al.  Dynamic proteomics in modeling of the living cell. Protein-protein interactions , 2009, Biochemistry (Moscow).

[46]  B. Kholodenko Cell-signalling dynamics in time and space , 2006, Nature Reviews Molecular Cell Biology.

[47]  Edda Klipp,et al.  Modeling mechanistic biological networks: An advanced Boolean approach , 2012, Bioinform..

[48]  Christopher J. Oldfield,et al.  Intrinsically disordered protein. , 2001, Journal of molecular graphics & modelling.

[49]  S. Lee,et al.  Metabolic network modeling and simulation for drug targeting and discovery , 2012, Biotechnology journal.

[50]  Larry Norton,et al.  Translating Mathematical Modeling of Tumor Growth Patterns into Novel Therapeutic Approaches for Breast Cancer , 2012, Journal of Mammary Gland Biology and Neoplasia.

[51]  C R Scriver,et al.  Monogenic traits are not simple: lessons from phenylketonuria. , 1999, Trends in genetics : TIG.

[52]  E. Kunkel Systems biology in drug discovery , 2004, Nature Biotechnology.

[53]  H. Kaneto,et al.  Transcription factors as therapeutic targets for diabetes. , 2008, Expert opinion on therapeutic targets.

[54]  Alan F. Scott,et al.  Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders , 2004, Nucleic Acids Res..

[55]  Filippo Menolascina,et al.  Engineering and control of biological systems: A new way to tackle complex diseases , 2012, FEBS letters.

[56]  Edda Klipp,et al.  Biochemical network-based drug-target prediction. , 2010, Current opinion in biotechnology.

[57]  Yuan Qi,et al.  Modularity and Dynamics of Cellular Networks , 2006, PLoS Comput. Biol..

[58]  Alan F. Scott,et al.  Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders , 2002, Nucleic Acids Res..

[59]  M. Gerstein,et al.  Getting connected: analysis and principles of biological networks. , 2007, Genes & development.

[60]  Emma Saavedra,et al.  Metabolic Control Analysis: A Tool for Designing Strategies to Manipulate Metabolic Pathways , 2008, Journal of biomedicine & biotechnology.

[61]  Pall I. Olason,et al.  A human phenome-interactome network of protein complexes implicated in genetic disorders , 2007, Nature Biotechnology.

[62]  Ron Summers,et al.  Engineering Biology: Model Conceptualisation and Realisation , 2011 .

[63]  Tammy M. K. Cheng,et al.  Understanding cancer mechanisms through network dynamics. , 2012, Briefings in functional genomics.

[64]  Monika Heiner,et al.  BioModel engineering for multiscale Systems Biology. , 2013, Progress in biophysics and molecular biology.

[65]  P. J. Bhat,et al.  Can metabolic plasticity be a cause for cancer? Warburg–Waddington legacy revisited , 2011, Clinical Epigenetics.

[66]  U. Bhalla,et al.  Emergent properties of networks of biological signaling pathways. , 1999, Science.

[67]  A. Arkin,et al.  Motifs, modules and games in bacteria. , 2003, Current opinion in microbiology.

[68]  Gary D Bader,et al.  Dynamic interaction networks in a hierarchically organized tissue , 2010, Molecular systems biology.

[69]  Hiroyuki Ogata,et al.  KEGG: Kyoto Encyclopedia of Genes and Genomes , 1999, Nucleic Acids Res..

[70]  J. Doyle,et al.  Metabolic syndrome and robustness tradeoffs. , 2004, Diabetes.

[71]  Mark A. J. Chaplain,et al.  Mathematical modeling of cancer cell invasion of tissue: biological insight from mathematical analysis and computational simulation , 2011, Journal of mathematical biology.

[72]  A. Barabasi,et al.  The human disease network , 2007, Proceedings of the National Academy of Sciences.

[73]  J. Houtman,et al.  Examining multiprotein signaling complexes from all angles , 2005, The FEBS journal.

[74]  G. Saidel,et al.  Multi-Scale Computational Model of Fuel Homeostasis During Exercise: Effect of Hormonal Control , 2006, Annals of Biomedical Engineering.

[75]  I. Lavrik,et al.  Mathematical modeling of apoptosis , 2013, Cell Communication and Signaling.

[76]  Gilles Clermont,et al.  Computational disease modeling – fact or fiction? , 2009, BMC Systems Biology.

[77]  Lopamudra Giri,et al.  A steady state analysis indicates that negative feedback regulation of PTP1B by Akt elicits bistability in insulin-stimulated GLUT4 translocation , 2004, Theoretical Biology and Medical Modelling.

[78]  Kevin A. Janes,et al.  Multiscale Models of Cell Signaling , 2012, Annals of Biomedical Engineering.

[79]  Jeffrey D Orth,et al.  What is flux balance analysis? , 2010, Nature Biotechnology.

[80]  Carol Friedman,et al.  Discovery of Protein Interaction Networks Shared by Diseases , 2006, Pacific Symposium on Biocomputing.

[81]  Alfio Quarteroni,et al.  A vision and strategy for the virtual physiological human: 2012 update , 2013, Interface Focus.

[82]  Claudio Cobelli,et al.  Meal Simulation Model of the Glucose-Insulin System , 2007, IEEE Transactions on Biomedical Engineering.

[83]  A. Bauer-Mehren,et al.  Pathway databases and tools for their exploitation: benefits, current limitations and challenges , 2009, Molecular systems biology.

[84]  Ewart R. Carson,et al.  Modelling and control in biomedical systems , 2011, Comput. Methods Programs Biomed..

[85]  Yang Kuang,et al.  Mathematical models and software tools for the glucose-insulin regulatory system and diabetes: an overview , 2006 .

[86]  Tsviya Olender,et al.  Human Gene-Centric Databases at the Weizmann Institute of Science: GeneCards, UDB, CroW 21 and HORDE , 2003, Nucleic Acids Res..

[87]  Yoshihiro Ogawa,et al.  Integrated network systems and evolutionary developmental endocrinology. , 2010, Medical hypotheses.

[88]  D. Wilkinson Stochastic modelling for quantitative description of heterogeneous biological systems , 2009, Nature Reviews Genetics.

[89]  Teresa M Przytycka,et al.  Network integration meets network dynamics , 2010, BMC Biology.

[90]  D. K. Arrell,et al.  Network Systems Biology for Drug Discovery , 2010, Clinical pharmacology and therapeutics.

[91]  Vittorio Cristini,et al.  Multiscale cancer modeling. , 2010, Annual review of biomedical engineering.

[92]  Andrei Zinovyev,et al.  Cell death and life in cancer: mathematical modeling of cell fate decisions. , 2013, Advances in experimental medicine and biology.

[93]  B. Mayer Protein-protein interactions in signaling cascades. , 1998, Methods in molecular biology.

[94]  M. Peitsch,et al.  The application of systems biology to drug discovery. , 2006, Current opinion in chemical biology.

[95]  R. Sharan,et al.  Protein networks in disease. , 2008, Genome research.

[96]  Hans-Dieter Pohlenz,et al.  PhenomicDB: a multi-species genotype/phenotype database for comparative phenomics , 2005, Bioinform..

[97]  Victor Neduva,et al.  Peptides mediating interaction networks: new leads at last. , 2006, Current opinion in biotechnology.

[98]  B. Kholodenko,et al.  Computational Approaches for Analyzing Information Flow in Biological Networks , 2012, Science Signaling.

[99]  S. Sestini,et al.  Genetic studies of diseases , 2007, Cellular and Molecular Life Sciences.

[100]  U. Alon Network motifs: theory and experimental approaches , 2007, Nature Reviews Genetics.

[101]  J. Stelling,et al.  Robustness of Cellular Functions , 2004, Cell.

[102]  Cheng-Liang Chen,et al.  Modeling the physiological glucose-insulin dynamic system on diabetics. , 2010, Journal of theoretical biology.

[103]  P. Clemons,et al.  Target identification and mechanism of action in chemical biology and drug discovery. , 2013, Nature chemical biology.

[104]  Fusheng Tang,et al.  A molecular mathematical model of glucose mobilization and uptake. , 2009, Mathematical biosciences.

[105]  K.G. Gadkar,et al.  Towards Optimal Virtual Patients: An Online Adaptive Control Approach , 2007, 2007 29th Annual International Conference of the IEEE Engineering in Medicine and Biology Society.

[106]  Alexandra Piryatinska,et al.  Mathematical modeling of tumor cell proliferation kinetics and label retention in a mouse model of lung cancer. , 2013, Cancer research.

[107]  D. F. Waugh,et al.  Protein-protein interactions. , 1954, Advances in protein chemistry.

[108]  Peter Hunter,et al.  Integration from proteins to organs: the IUPS Physiome Project , 2005, Mechanisms of Ageing and Development.

[109]  Hiroaki Kitano,et al.  Structure of Protein Interaction Networks and Their Implications on Drug Design , 2009, PLoS Comput. Biol..

[110]  John Hornberger,et al.  Computer Modeling of Diabetes and Its Complications , 2007, Diabetes Care.

[111]  N H Holford,et al.  Drug treatment effects on disease progression. , 2001, Annual review of pharmacology and toxicology.

[112]  Lee Suan Chua,et al.  Modeling of glucose regulation and insulin-signaling pathways , 2009, Molecular and Cellular Endocrinology.

[113]  Edwin Wang,et al.  A Roadmap of Cancer Systems Biology , 2010 .

[114]  G. D. Gatta,et al.  Systems and Synthetic biology: tackling genetic networks and complex diseases , 2009, Heredity.

[115]  Antonio Bertoletti,et al.  The Host–pathogen Interaction during HBV Infection: Immunological Controversies , 2010, Antiviral therapy.

[116]  Nagasuma Chandra,et al.  Computational systems approach for drug target discovery , 2009, Expert opinion on drug discovery.

[117]  V. Uversky Intrinsically Disordered Proteins , 2014 .

[118]  Kiran Raosaheb Patil,et al.  Metabolic Network Topology Reveals Transcriptional Regulatory Signatures of Type 2 Diabetes , 2010, PLoS Comput. Biol..

[119]  Richard N Bergman,et al.  The minimal model of glucose regulation: a biography. , 2003, Advances in experimental medicine and biology.

[120]  J. Ferrell,et al.  Interlinked Fast and Slow Positive Feedback Loops Drive Reliable Cell Decisions , 2005, Science.

[121]  C. Ouzounis,et al.  Expansion of the BioCyc collection of pathway/genome databases to 160 genomes , 2005, Nucleic acids research.

[122]  Maricel G. Kann,et al.  Protein interactions and disease: computational approaches to uncover the etiology of diseases , 2007, Briefings Bioinform..

[123]  A. Barabasi,et al.  Drug—target network , 2007, Nature Biotechnology.

[124]  J. Hopfield,et al.  From molecular to modular cell biology , 1999, Nature.

[125]  H. Kitano Towards a theory of biological robustness , 2007, Molecular systems biology.

[126]  Dongqing Wei,et al.  Progress in the applications of flux analysis of metabolic networks , 2010 .

[127]  A. Sherman,et al.  A mathematical model of metabolic insulin signaling pathways. , 2002, American journal of physiology. Endocrinology and metabolism.

[128]  Jan A M Raaijmakers,et al.  Systems biology in pharmacogenomic research: the way to personalized prescribing? , 2009, Pharmacogenomics.

[129]  Hulin Wu,et al.  Multi-scale agent-based modeling on melanoma and its related angiogenesis analysis , 2013, Theoretical Biology and Medical Modelling.

[130]  Nathan D. Price,et al.  Mechanistic modeling of aberrant energy metabolism in human disease , 2012, Front. Physio..

[131]  P. S. Thiagarajan,et al.  Modeling and Analysis of biopathways Dynamics , 2012, J. Bioinform. Comput. Biol..

[132]  F. Rosselli,et al.  3R coordination by Fanconi anemia proteins. , 2005, Biochimie.

[133]  Michael Ederer,et al.  Reduced modeling of signal transduction – a modular approach , 2007, BMC Bioinformatics.

[134]  Gert Vriend,et al.  GeneSeeker: extraction and integration of human disease-related information from web-based genetic databases , 2005, Nucleic Acids Res..

[135]  Shayn M Peirce,et al.  Multiscale computational models of complex biological systems. , 2013, Annual review of biomedical engineering.

[136]  A. Mardinoğlu,et al.  Systems medicine and metabolic modelling , 2012, Journal of internal medicine.

[137]  Frances S. Turner,et al.  Computational disease gene identification: a concert of methods prioritizes type 2 diabetes and obesity candidate genes , 2006, Nucleic acids research.

[138]  Sarah R. Langley,et al.  Proteomics: from single molecules to biological pathways , 2012, Cardiovascular research.

[139]  Jason A. Papin,et al.  Reconstruction of cellular signalling networks and analysis of their properties , 2005, Nature Reviews Molecular Cell Biology.

[140]  Florian Nigsch,et al.  Recent trends and observations in the design of high-quality screening collections. , 2011, Future medicinal chemistry.

[141]  D. Butler Computing 2010: from black holes to biology , 1999, Nature.

[142]  Ian David Lockhart Bogle,et al.  The role of Computer Aided Process Engineering in physiology and clinical medicine , 2010, Comput. Chem. Eng..

[143]  C. Cobelli,et al.  Glucose effectiveness and insulin sensitivity from the minimal models: consequences of undermodeling assessed by Monte Carlo simulation , 1999, IEEE Transactions on Biomedical Engineering.

[144]  Nagasuma R. Chandra,et al.  Metabolome Based Reaction Graphs of M. tuberculosis and M. leprae: A Comparative Network Analysis , 2007, PloS one.

[145]  Michael B. Yaffe,et al.  Data-driven modelling of signal-transduction networks , 2006, Nature Reviews Molecular Cell Biology.

[146]  H. Häring,et al.  [Pathophysiology of insulin resistance]. , 1995, Herz.

[147]  V. Shahrezaei,et al.  The stochastic nature of biochemical networks. , 2008, Current opinion in biotechnology.

[148]  E. Wang,et al.  Genetic studies of diseases , 2007, Cellular and Molecular Life Sciences.

[149]  Jason A. Papin,et al.  Applications of genome-scale metabolic reconstructions , 2009, Molecular systems biology.

[150]  Markus J. Herrgård,et al.  Reconstruction of microbial transcriptional regulatory networks. , 2004, Current opinion in biotechnology.

[151]  A. Barabasi,et al.  The impact of cellular networks on disease comorbidity , 2009, Molecular systems biology.

[152]  Wei Jiang,et al.  The analysis of the drug–targets based on the topological properties in the human protein–protein interaction network , 2009, Journal of drug targeting.

[153]  Christopher L. McClendon,et al.  Reaching for high-hanging fruit in drug discovery at protein–protein interfaces , 2007, Nature.

[154]  Stephen Coombes,et al.  Mathematical Modeling of Glucose Homeostasis and Its Relationship With Energy Balance and Body Fat , 2009, Obesity.

[155]  L. Lesko,et al.  Use of biomarkers and surrogate endpoints in drug development and regulatory decision making: criteria, validation, strategies. , 2001, Annual review of pharmacology and toxicology.

[156]  P. Aloy,et al.  A network medicine approach to human disease , 2009, FEBS letters.

[157]  H. Kitano Systems Biology: A Brief Overview , 2002, Science.

[158]  R. Linding,et al.  Network‐based drugs and biomarkers , 2010, The Journal of pathology.

[159]  F. Jordán,et al.  Studying protein-protein interaction networks: a systems view on diseases. , 2012, Briefings in functional genomics.

[160]  D. Botstein,et al.  Construction of a genetic linkage map in man using restriction fragment length polymorphisms. , 1980, American journal of human genetics.

[161]  Zhiwei Wang,et al.  Proof of Concept: Network and Systems Biology Approaches Aid in the Discovery of Potent Anticancer Drug Combinations , 2010, Molecular Cancer Therapeutics.

[162]  Hélène Decornez,et al.  Early phase drug discovery: cheminformatics and computational techniques in identifying lead series. , 2012, Bioorganic & medicinal chemistry.

[163]  James A. Eddy,et al.  In silico models of cancer , 2010, Wiley interdisciplinary reviews. Systems biology and medicine.

[164]  D. Moller,et al.  New drug targets for type 2 diabetes and the metabolic syndrome , 2001, Nature.

[165]  Ping Zhang,et al.  Computer modeling of diabetes and its complications: a report on the Fifth Mount Hood challenge meeting. , 2007, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[166]  Kathy Chen,et al.  Network dynamics and cell physiology , 2001, Nature Reviews Molecular Cell Biology.

[167]  Mehmet Koyutürk Algorithmic and analytical methods in network biology , 2010, Wiley interdisciplinary reviews. Systems biology and medicine.

[168]  Caitlin Smith,et al.  A question of form , 2003, Nature.

[169]  Obert,et al.  A Model of b-Cell Mass , Insulin , and Glucose Kinetics : Pathways to Diabetes , 2000 .

[170]  Arne Traulsen,et al.  A deterministic model for the occurrence and dynamics of multiple mutations in hierarchically organized tissues , 2013, Journal of The Royal Society Interface.

[171]  Bernhard O. Palsson,et al.  The human metabolic reconstruction Recon 1 directs hypotheses of novel human metabolic functions , 2011, BMC Systems Biology.

[172]  D. Lauffenburger,et al.  Applying computational modeling to drug discovery and development. , 2006, Drug discovery today.

[173]  S. Leibler,et al.  Robustness in simple biochemical networks , 1997, Nature.

[174]  R. Miura,et al.  A Model of β -Cell Mass, Insulin, and Glucose Kinetics: Pathways to Diabetes , 2000 .